These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 16200777

  • 1. [Clinical tolerance test of recombinant human thrombopoietin].
    Zhao Y, Jiang J, Jiao L.
    Zhonghua Yi Xue Za Zhi; 2001 Dec 25; 81(24):1508-11. PubMed ID: 16200777
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH, Chen ZW, Ye XY, Lu S.
    Zhonghua Zhong Liu Za Zhi; 2008 Sep 25; 30(9):716-9. PubMed ID: 19173920
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Value of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Dai XF, Yu J, Liu L, Wu G.
    Zhonghua Zhong Liu Za Zhi; 2008 Aug 25; 30(8):623-5. PubMed ID: 19102944
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura].
    Zhao YQ, Wang QY, Zhai M, Xu J, Chen XQ, Liu WL, Zhang M, Song SJ, Wang JM, Meng FY, Shan YD.
    Zhonghua Nei Ke Za Zhi; 2004 Aug 25; 43(8):608-10. PubMed ID: 15355668
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical studies with megakaryocyte growth and development factor (Mpl-ligand).
    Begley CG.
    Thromb Haemost; 1997 Jul 25; 78(1):42-6. PubMed ID: 9198125
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study.
    Wu Q, Ren J, Wu X, Wang G, Gu G, Liu S, Wu Y, Hu D, Zhao Y, Li J.
    J Crit Care; 2014 Jun 25; 29(3):362-6. PubMed ID: 24405656
    [Abstract] [Full Text] [Related]

  • 19. Recombinant human thrombopoietin in combination with cyclosporin A as a novel therapy in corticosteroid-resistant primary immune thrombocytopenia.
    Cui ZG, Liu XG, Qin P, Hou M, Wu SL, Peng J, Zhao HG, Wang HY, Zhao CT.
    Chin Med J (Engl); 2013 Nov 25; 126(21):4145-8. PubMed ID: 24229688
    [Abstract] [Full Text] [Related]

  • 20. A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
    Nash RA, Kurzrock R, DiPersio J, Vose J, Linker C, Maharaj D, Nademanee AP, Negrin R, Nimer S, Shulman H, Ashby M, Jones D, Appelbaum FR, Champlin R.
    Biol Blood Marrow Transplant; 2000 Nov 25; 6(1):25-34. PubMed ID: 10707996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.